Zachary A Marcum, Jordana B Cohen, Eric B Larson, Jeff Williamson, Adam P Bress
{"title":"优先处方血管紧张素 II 受体阻滞剂 (ARB) 而非血管紧张素转换酶抑制剂 (ACEI) 能否降低痴呆风险并改善脑健康公平性?","authors":"Zachary A Marcum, Jordana B Cohen, Eric B Larson, Jeff Williamson, Adam P Bress","doi":"10.31478/202205c","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74236,"journal":{"name":"NAM perspectives","volume":"2022 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499377/pdf/nampsp-2022-202205c.pdf","citationCount":"0","resultStr":"{\"title\":\"Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?\",\"authors\":\"Zachary A Marcum, Jordana B Cohen, Eric B Larson, Jeff Williamson, Adam P Bress\",\"doi\":\"10.31478/202205c\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74236,\"journal\":{\"name\":\"NAM perspectives\",\"volume\":\"2022 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499377/pdf/nampsp-2022-202205c.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NAM perspectives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31478/202205c\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAM perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31478/202205c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?